Invention Grant
- Patent Title: Heterocyclic compounds useful as dual ATX/CA inhibitors
-
Application No.: US16569475Application Date: 2019-09-12
-
Publication No.: US11059794B2Publication Date: 2021-07-13
- Inventor: Patrizio Mattei , Jérôme Hert , Daniel Hunziker , Markus Rudolph , Petra Schmitz , Patrick Di Giorgio , Justin Gomme
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Katherine J. Mackenzie
- Priority: EP17161249 20170316
- Main IPC: C07D257/04
- IPC: C07D257/04 ; C07D401/06 ; C07D401/10 ; C07D401/12 ; C07D401/14 ; C07D403/10 ; C07D405/12 ; C07D405/14 ; C07D409/14 ; C07D417/14
Abstract:
The invention provides novel compounds having the general formula (I) wherein R1, R2, Y, X, W, m and n are as defined herein, compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20200002297A1 HETEROCYCLIC COMPOUNDS USEFUL AS DUAL ATX/CA INHIBITORS Public/Granted day:2020-01-02
Information query
